By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that while nuclear demand is surging, the market is overpricing the 'renaissance' due to execution risks, geopolitical bottlenecks, and regulatory timelines. They favored the fuel cycle over unproven modular reactor designs until these companies demonstrate positive free cash flow.
Risk: Enrichment bottlenecks and HALEU fuel shortages could idle SMRs for years, collapsing the 'AI-driven 40GW by 2030' thesis and depressing near-term uranium demand.
Opportunity: Cameco (CCJ) offers direct exposure to uranium spot prices and is considered a strategic security asset due to the scarcity of non-Russian fuel cycle capacity.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Nuclear power can provide clean, baseload power to a world increasingly turning to electricity as its primary energy source.
Industry suppliers like Brookfield Renewable and Cameco, and industry innovators like NuScale and Oklo, are all good options.
Cameco (NYSE: CCJ) estimates that demand for nuclear power is growing so rapidly that uranium supply will be outstripped in the 2030s. According to the company, 72 new reactors are under construction, while older reactors are being restarted or having their lifespans extended. The nuclear boom is real as the world leans into a clean baseload power source.
Cameco and fellow industry service provider Brookfield Renewable (NYSE: BEP) are good choices for more conservative investors looking to get into the nuclear power sector. More aggressive types may prefer NuScale (NYSE: SMR) or Oklo (NYSE: OKLO). Here's why.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
NuScale Power and Oklo are both attempting to create businesses around small modular reactors. At this point, each company has a design, but neither has built a reactor connected to the electrical grid. They are each losing money and will likely continue to do so for a while longer. However, small modular nuclear reactors are a potentially important technological advance. If the technology takes off, NuScale and Oklo could have a long runway for growth ahead.
The problem, of course, is the risk that the technology doesn't gain traction. And even if it does, it's unclear whether both companies will be long-term survivors. Even aggressive investors should tread with caution and, perhaps, consider buying a little of each to hedge their bets.
Cameco, highlighted above, produces nuclear fuel. The supply and-demand dynamic it expects to unfold would lead to rising uranium prices. And that, in turn, would be very good for Cameco's profits. It already has a long and successful history in the industry and is a reliable fuel supplier to nuclear power plants worldwide. While it is a good way to get exposure to a picks-and-shovels nuclear play, the stock is already on the rise, up over 300% in the last three years. Some investors may prefer another option.
Cameco also owns 50% of Westinghouse, with Brookfield Renewable owning the other 50%. Westinghouse designs reactors and helps to build and service them. It generates more consistent revenues than selling fuel, helping to smooth out Cameco's financial results. For Brookfield Renewable, Westinghouse simply supplements the cash flow generated by its global portfolio of clean energy assets. That cash flow backs a lofty 4.5% yield.
If Cameco is like jumping in with both feet, Brookfield Renewable is like dipping a toe in the water. For more conservative investors and those with a dividend focus, just a toe might be the perfect option.
Electric vehicles, artificial intelligence, and data centers, among other things, are increasing electricity demand. Nuclear is being looked at as a way to meet demand. Advanced technology from Oklo and NuScale offers potential long-term opportunities, but owning the stocks is high risk. Cameco and Brookfield Renewable are more established industry players, with Brookfield Renewable standing out as a lower-risk income option.
Before you buy stock in Oklo, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oklo wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $475,926! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,296,608!
Now, it’s worth noting Stock Advisor’s total average return is 981% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 8, 2026. *
Reuben Gregg Brewer has positions in Brookfield Renewable Partners. The Motley Fool has positions in and recommends Cameco. The Motley Fool recommends Brookfield Renewable Partners and NuScale Power. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"The valuation of small modular reactor firms like Oklo and NuScale is currently untethered from operational reality, making fuel-cycle incumbents like Cameco the only viable way to play the nuclear theme."
The nuclear narrative is currently driven by AI-induced electricity demand, but the article ignores the brutal reality of capital expenditure (CapEx) and regulatory timelines. While Cameco (CCJ) offers direct exposure to uranium spot prices—which have historically been volatile—it remains the most rational play. However, labeling NuScale (SMR) or Oklo (OKLO) as 'investments' is generous; they are speculative R&D vehicles with zero commercial revenue. The market is pricing in a 'renaissance' that assumes perfect execution in a sector notorious for multi-year delays and massive cost overruns. Investors should favor the fuel cycle over unproven modular reactor designs until these companies demonstrate positive free cash flow.
If the U.S. government prioritizes energy security over fiscal discipline, the massive federal subsidies and streamlined permitting for SMRs could turn these 'unproven' designs into the next generation of essential infrastructure.
"Nuclear theme intact, but CCJ's 300% run-up prices in a prolonged supply crunch unlikely amid accelerating mine restarts and exploration."
Nuclear demand is surging—data centers alone could add 40GW by 2030 per IEA estimates—but the article cherry-picks winners while downplaying execution risks. CCJ (Cameco) spot uranium prices have spiked to $90/lb, but new supply from Kazakhstan (Kazatomprom ramping 25% output) and Australia could cap prices below $100/lb needed for CCJ's tier-1 margins. SMR/OKLO remain vaporware: NuScale's Idaho project ballooned from $5B to $9B+ before cancellation; Oklo's Aurora microreactor awaits NRC approval, years away. BEP's Westinghouse stake (50% owned with CCJ) adds stable service revenue (~$1B EBITDA), propping 4.5% yield, but it's <20% of BEP's hydro/wind portfolio. Frothy valuations (CCJ 45x fwd P/E) scream pullback risk.
If global reactor builds hit 72+ as Cameco forecasts with minimal supply response, uranium scarcity drives CCJ margins to 40%+ and SMR/OKLO first-mover moats solidify for trillion-dollar markets.
"The nuclear thesis is sound, but Cameco's valuation already embeds much of the upside, while NuScale and Oklo have zero operational proof and no credible path to cash flow within 5-7 years."
The article conflates a genuine structural tailwind (nuclear demand) with stock selection clarity it doesn't possess. Yes, 72 reactors under construction and AI-driven power demand are real. But Cameco up 300% in three years means much of this is priced in—and uranium spot prices would need to sustain $80+ to justify current valuations. Brookfield Renewable's 4.5% yield is attractive, but the article glosses over that Westinghouse (50% owned by Cameco) remains loss-making and capital-intensive. NuScale and Oklo are presented as 'high risk' but lack any quantified path to profitability or grid deployment timelines. The article also omits: regulatory risk (NRC licensing delays), competition from renewables+storage, and whether SMRs achieve cost parity with large reactors.
If uranium supply genuinely tightens in the 2030s as Cameco claims, the current 300% run-up is still underpriced relative to a multi-decade bull market; the article's caution may be excessive for long-term holders.
"The core risk is that timing, regulation, and costs will delay real demand and keep upstream returns volatile, limiting upside absent a rapid, credible commercialization of SMRs and sustained uranium price increases."
Strong narrative: nuclear could be a clean baseload. But the strongest miss in the article is the timing risk and capital discipline. Even if 72 reactors are under construction, licensing, construction overruns, and cancellations can push demand normalization well into the 2030s or later. SMR developers face chronic regulatory, sourcing, and cost risks; neither NuScale nor Oklo has a grid-connected reactor yet. Cameco and Brookfield Renewable rely on commodity prices and project pipelines, which are volatile and sensitive to uranium supply—price spikes are not assured. Valuations already reflect growth; a clean energy rally could fade if policy support wanes or rates rise.
Devil's advocate: if policy support remains robust and SMR pilots monetize sooner than expected, the upside could materialize quickly; but the risk of policy withdrawal or delays remains the bigger, steadier drag.
"Western utilities' forced decoupling from Russian enrichment services creates a structural floor for Cameco's valuation that transcends commodity spot-price volatility."
Grok, your focus on Kazatomprom is vital, but you're missing the geopolitical bottleneck: enrichment. Even if uranium supply hits the market, Western utilities are actively decoupling from Russian enrichment services. This creates a supply-chain premium that spot prices alone don't capture. CCJ isn't just a commodity play; it’s a strategic security asset. While you fear a pullback on 45x P/E, the scarcity of non-Russian fuel cycle capacity creates a floor that valuation multiples currently fail to account for.
"CCJ lacks enrichment exposure, and HALEU shortages pose an unaddressed SMR killer regardless of uranium mining supply."
Gemini, your enrichment decoupling point overlooks that CCJ's fuel services focus on conversion/refining—not enrichment, where Russia controls ~44% of global capacity per WNA data. Western alternatives (Urenco expansions, Centrus HALEU pilots) face their own multi-year delays and $multi-billion CapEx. This chain vulnerability doesn't floor CCJ; it amplifies pullback risk on 45x P/E if any link snaps. Unmentioned: HALEU fuel shortages alone could idle SMRs for years.
"Enrichment delays are a harder constraint than uranium scarcity, and neither panelist has priced in the risk that SMRs become stranded assets before fuel supply catches up."
Grok and Gemini are both correct but talking past each other. Enrichment *is* the binding constraint—not uranium ore. But Grok's HALEU shortage point is underexplored: if Western SMRs can't fuel up for years, the entire 'AI-driven 40GW by 2030' thesis collapses on logistics, not demand. CCJ's 45x P/E assumes fuel cycle tightness; if enrichment bottlenecks idle reactors, that multiple compresses hard. Neither panelist quantified how many years SMRs sit dark waiting for HALEU.
"HALEU supply delays could become a multi-year headwind that dampens SMR deployment and narrows CCJ's upside beyond spot uranium expectations."
Grok's focus on HALEU shortages is valid, but the real sensitivity is duration. If HALEU supply lags by 3–5 years, SMR pilots slide into limp-start mode, forcing utilities to de-risk by locking extended fuel contracts or postponing builds. That could depress near-term uranium demand and CCJ's fuel-services margins, making the stock look pricier vs. a broader energy-services play. A longer wait also risks policy shifts eroding the bear-case anyway.
The panelists generally agreed that while nuclear demand is surging, the market is overpricing the 'renaissance' due to execution risks, geopolitical bottlenecks, and regulatory timelines. They favored the fuel cycle over unproven modular reactor designs until these companies demonstrate positive free cash flow.
Cameco (CCJ) offers direct exposure to uranium spot prices and is considered a strategic security asset due to the scarcity of non-Russian fuel cycle capacity.
Enrichment bottlenecks and HALEU fuel shortages could idle SMRs for years, collapsing the 'AI-driven 40GW by 2030' thesis and depressing near-term uranium demand.